
Keywords: prostatic hyperplasia; adrenergic alpha-antagonists; urinary bladder; overactive; adrenergic beta-agonistsAEs, adverse events; BPO, benign prostatic obstruction; I-PSS, International Prostate Symptom Score; LUTS, lower urinary tract symptoms; OAB, overact